Magnetic resonance imaging (MRI) is increasingly used in autosomal dominant polycystic kidney disease (ADPKD) for diagnosis, classification, assessment of disease progression and treatment response, and for identifying complications. Herein we review the role of MRI in the management of patients with ADPKD. We show how MRI-derived total kidney volume is a biomarker for assessing ADPKD severity and predicting decline in renal function. We also demonstrate the MR appearances of common complications. Level of Evidence: 3 Technical Efficacy Stage: 5 J. Magn. Reson. Imaging 2019;50:41-51.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jmri.26627 | DOI Listing |
Publication Analysis
Top Keywords
autosomal dominant
8
dominant polycystic
8
polycystic kidney
8
kidney disease
8
mri autosomal
4
disease magnetic
4
magnetic resonance
4
resonance imaging
4
imaging mri
4
mri increasingly
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!